Cargando…
Serum IgG-induced microglial activation enhances neuronal cytolysis via the NO/sGC/PKG pathway in children with opsoclonus-myoclonus syndrome and neuroblastoma
BACKGROUND: Opsoclonus-myoclonus syndrome (OMS) is a rare neurological disease. Some children with OMS also have neuroblastoma (NB). We and others have previously documented that serum IgG from children with OMS and NB induces neuronal cytolysis and activates several signaling pathways. However, the...
Autores principales: | Ding, Xu, Yang, Wei, Ren, Qinghua, Hu, Jiajian, Yang, Shen, Han, Wei, Wang, Jing, Wang, Xu, Wang, Huanmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298801/ https://www.ncbi.nlm.nih.gov/pubmed/32546235 http://dx.doi.org/10.1186/s12974-020-01839-9 |
Ejemplares similares
-
Primary pancreatic neuroblastoma presenting with opsoclonus–myoclonus syndrome
por: Galgano, Samuel, et al.
Publicado: (2015) -
Long-term neurological outcomes of children with neuroblastoma with opsoclonus-myoclonus syndrome
por: Sun, Qing, et al.
Publicado: (2022) -
Neuroblastoma presenting as opsoclonus-myoclonus: A series of six cases and review of literature
por: Meena, Jagdish P., et al.
Publicado: (2016) -
The Role of NO/sGC/cGMP/PKG Signaling Pathway in Regulation of Platelet Function
por: Gambaryan, Stepan
Publicado: (2022) -
Clinical Responses to Rituximab in a Case of Neuroblastoma with Refractory Opsoclonus Myoclonus Ataxia Syndrome
por: Alavi, Samin, et al.
Publicado: (2012)